Detalhe da pesquisa
1.
Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.
Hepatology
; 74(2): 776-796, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619771
2.
Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.
Gut
; 69(2): 329-342, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439637
3.
Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
Hepatology
; 69(6): 2502-2517, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723918
4.
HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma.
Hepatology
; 69(5): 2013-2030, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516846
5.
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Hepatology
; 67(6): 2254-2270, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29171881
6.
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
J Hepatol
; 67(4): 758-769, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28532996
7.
Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Hepatology
; 63(2): 474-87, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26481868
8.
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
Hepatology
; 60(5): 1645-58, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048396
9.
Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
Hepatology
; 57(2): 637-47, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22991213
10.
In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
Cell Mol Gastroenterol Hepatol
; 14(5): 1053-1076, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944892
11.
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC.
Nat Commun
; 10(1): 4681, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615983
12.
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
Nat Rev Gastroenterol Hepatol
; 15(3): 137-151, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29317776
13.
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer.
Oncogenesis
; 7(5): 44, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29799025
14.
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.
Nat Commun
; 8(1): 517, 2017 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28894087
15.
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.
J Clin Invest
; 127(5): 1856-1872, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28394261
16.
MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.
Front Med
; 9(3): 331-43, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26293610
17.
MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
Oncotarget
; 6(15): 13658-70, 2015 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25909223
18.
Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
PLoS One
; 9(12): e115036, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25541689
19.
Regulation of hepatocarcinogenesis by microRNAs.
Front Biosci (Elite Ed)
; 5(1): 49-60, 2013 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23276969